June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Evaluating the central visual field with a reduced density test pattern and size V stimulus
Author Affiliations & Notes
  • Collins Opoku-Baah
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Gary C Lee
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Buck Cunningham
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Thomas Callan
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Luke Chong
    School of Medicine (Optometry), Deakin University, Geelong, Victoria, Australia
  • John G Flanagan
    Herbert Wertheim School of Optometry and Vision Science, University of California Berkeley, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Collins Opoku-Baah Carl Zeiss Meditec, Inc., Heru, Inc., Code E (Employment); Gary Lee Carl Zeiss Meditec, Inc., Code E (Employment); Buck Cunningham Carl Zeiss Meditec, Inc., Code E (Employment); Thomas Callan Carl Zeiss Meditec, Inc., Code E (Employment); Luke Chong Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Inc., Code F (Financial Support); John Flanagan Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Inc., Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5500. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Collins Opoku-Baah, Gary C Lee, Buck Cunningham, Thomas Callan, Luke Chong, John G Flanagan; Evaluating the central visual field with a reduced density test pattern and size V stimulus. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5500.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The size V stimulus has been found to have a greater dynamic range and improved repeatability [1] and is able to efficiently detect early glaucoma. We compared the diagnostic performance of a visual field test (VF) using a reduced number of test locations and the size V stimulus with the standard 10-2 test pattern.

Methods : VFs using the Full Threshold strategy were acquired on a HFA3 Model 840 perimeter (ZEISS, Dublin, CA) for three combinations of stimulus size and test pattern: size V, reduced (32 point) pattern; size III, reference (68 point) pattern; and size V, reference pattern (Fig 1). While VFs were acquired on two visits, only data from visit 1 were used for further analysis. Size III and V reference limits were interpolated from a previous study [2]. Mean deviations (MD) and fraction of abnormal test locations flagged at 5% level for total deviation (TD) were computed. Comparisons between the reduced and reference patterns were carried out using Bland-Altman 95% limits of agreement (LOA).

Results : The mean ages were 52.3 years (±14.5; 27.7 – 79.2; n=32) for the healthy group and 77.7 years (±5.3; 63.2 – 87.6; n=18) for those with glaucoma. Mean test duration (in minutes) was significantly shorter for the size V, reduced pattern (6.1±1.1) compared with the reference patterns using either the size III (11.1±1.7) and size V (11.1±1.9). MDs for the reduced pattern showed strong agreement with the reference patterns although slightly stronger for size V (r=0.98, LOA=-1.6, 2.3dB) than size III (r=0.97, LOA=-2.5, 4.1dB). Furthermore, there was a strong agreement between the reduced pattern and the reference patterns for both the size III (r=0.94, LOA=-0.21, 0.17) and size V (r=0.94, LOA=-0.22,0.16) in terms of the fraction of flagged points at 5% TD level (Fig 2). Visual inspection revealed good concordance between tests for the location of flagged points, with similar defects generally being present across all tests (Fig 1).

Conclusions : Our preliminary findings suggest similar diagnostic performance between the size V reduced pattern and the reference patterns. Future work is required to compare these tests in terms of the similarity of locations for flagged defects and the ability to detect clinically relevant central scotomas.

[1] Wall et al. Arch Ophthalmol 2010 128(5):570-6
[2] Flanagan et al. IOVS 2016; 57(12).

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×